Agranulocytosis is a condition characterised by a severe reduction of granulocytes in the blood, leading to leukopenia or lowered white blood cell count. The condition can severely compromise the immune system with patients unable to fight off infections. Weak microbes that usually cause no harm can become strong enough to cause serious damage to their body.
The condition is associated with the use of several pharmaceutical drugs such as antidepressants, antiepileptics, antibiotics, and non-steroidal anti-inflammatory drugs. There are cases of agranulocytosis in which patients do not exhibit any symptoms but may develop a sudden fever, sore throat, and rigours. The infection may spread to internal organs, and there is a high risk of septicemia or severe injury to affected organs that can lead to death. The delicate nature of this disease warrants the need for an accurate diagnosis using state-of-the-art laboratory and diagnostic tools.
In Southeast Asian countries such as Singapore, Malaysia, and Thailand, there are numerous medical facilities that offer comprehensive treatment for this condition. They are fully equipped to perform bone marrow biopsy and various diagnostic tests, including genetic testing, to make an accurate diagnosis. In severe cases where the patient requires aggressive treatment such as chemotherapy and bone marrow transplant, internationally-recognised hospitals in the region can also offer such procedures using the most advanced technologies and evidence-based methods.
Aside from modern medical facilities and advanced medical equipment, many hospitals in Southeast Asian countries mentioned above are also staffed by highly trained haematologists and immunologists who can team up with other medical specialists to provide patients with holistic treatment. Many doctors in the region have completed their medical degree in Western countries such as the United States and the United Kingdom. As such, they can provide the highest level of care that meets international standards.